DOCSLIB.ORG

Addressing Prescription Pain Medicine Abuse & Misuse

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Addressing Prescription Pain Medicine Abuse & Misuse American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Guidelines and Recommendations “Federal and State Laws Relating to the 1. Standards For The Use Of Controlled Substances Prescribing of Controlled Substances”. For Treatment Of Pain; AHCA in consultation with The Florida Pain Commission, The Florida Board of • Walter B. Flesner III, D.O. Medicine, and The Florida Board of Osteopathic • Past President, FOMA, 1996-1997. Medicine, Revised 12-21-99. 2. JCAHO Standards 1999 3. Federation of State Medical Boards Joint Concensus • Past President, FOMA District XI, 2008-2010. 4. Federal Controlled Substances Act 1970 • Medical Director, ICP&R, Cape Coral, Fl. 5. DEA Statements. • Risk Management/Continuing Medical Education 6. Florida House/Senate Bills 7095,0462, and 2272, Florida Statute Chapter 893, 456.44, 459.0137,64B- American Osteopathic College of Occupational and 15-14.005. 7.Risk Evaluation Preventive Medicine Midyear Seminar. and Mitigation Strategy 8.E-Forcse-PDMP. 9. • Sunday, Sunday March 15th, Ft. Lauderdale, Fl. Lee County Coalition for a Drug-Free South West Florida. Walter B. Flesner III, D.O. Medical Director ICP&R Florida Statistics • 7 Floridians die daily from lethal overdoses. Additional 7 persons die daily with at least one prescription drug detected in combination with Addressing Prescription alcohol or other drugs. Florida led nation in sale of Pain Medicine Abuse & Misuse: Oxycodone with over 400,000,000 pills sold A Framework For Safe Prescribing annually! However down 20% in past year. How Prescription Drugs get to Floridians: 1. Physicians and Pharmacists- for profit, naïve, impaired. 2. Individuals- illegally obtain to satisfy addiction, traffic or divert for profit or to family or friend. 1. 3. Internet pharmacies- major difficult threat. Z-1 American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Solutions Be part of the solution, not part of the problem. You are here! Learn new guidelines, talk to your colleagues, consult specialists when indicated. Florida BOM, FBM, DEA, FDLA, State, County, Local law enforcement, State Attorney’s Off., FOMA, FMA, Specialty Societies- we all need to work together so legitimate acute, chronic, and terminal pain patients can have appropriate access to compassionate and multidisciplinary care. Urine drug testing, the Prescription Drug Monitoring Program (PDMP)- E-FORCSE.com, and patient-doctor opioid agreements have started to help. New Zoning Laws are coming for new Pain Clinics. Definition of Pain Definitions IASP definition:* • Tolerance Pain is “an unpleasant sensory and emotional experience Pseudotolerance associated with actual or potential tissue injury or Physical Dependence described in terms of such damage.” Addiction Importance of the patient’s self-report: Pseudoaddiction “Pain is whatever the experiencing person says it is, Substance Abuse existing whenever he/she says it does.”** Acute Pain Chronic Pain * IASP. Pain 1979;6:249-252. ** McCaffery M, Beebe A. Pain: Clinical Manual for Nursing Practice. St Louis: CV Mosby Company; 1989. Tolerance: Pseudotolerance: • the need for increased dosage of medication • need to increase dosage is not due to to produce same level of analgesia that tolerance, but due to other factors such as existed previously. Tolerance occurs also when disease progression, increased activity, drug a reduced effect is observed with constant interaction, new disease, other medication doses. Analgesic tolerance is not always seen changes, or deviant behavior. during opioid treatment and is not addiction. Z-2 American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Physical dependence: Addiction: • Occurrence of withdrawal • psychological dependence on the use of symptom/syndromes after opioid use is substances and their psychic effects and/or stopped abruptly or decreased without compulsive use of drugs over which patients titration. It can also occur if an antagonist is no longer have control, and continue to use administered. Physical dependence is NOT despite harm to themselves or others. addiction! It does not always occur with Addiction is a disease. opioid usage, but is a common phenomenon with opioid treatment. Pseudoaddiction: • drug-seeking behavior that may seem similar to addiction, but is due to unrelieved or incompletely relieved pain. Often after a dosage increase, the behavior stops once the pain is relieved. Substance Abuse: Acute Pain: • use of any substance for non-therapeutic • normal predicted physiological response to an purposes. adverse chemical, thermal, or mechanical stimulus and is associated with trauma, surgery, or acute illness. It usually resolves within 3 months. • Subacute Pain: 3-6 months. • Chronic pain: > 3-6 months. Z-3 American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Keys to Appropriate Pain Chronic Pain: Assessment • Complete initial assessment • • state in which pain is persistent and cannot be Use appropriate tools removed or otherwise cured. It usually has – patient self-report occurred for more than 6 months. – easily administered rating scales 456.44: Chronic nonmalignant pain means pain – documentation forms available to all clinicians: Pain unrelated to cancer or rheumatoid arthritis which Assessment and Documentation Tool/ PADT, Opioid Risk persists beyond the usual course of disease or the Tool, Screener and Opioid Assessment for Patients with Pain/SOAPP. injury that is the cause of the pain or more than • 90 days after surgery. Assess pain at regular intervals • Be aware of common pain syndromes • Risk Identification and Stratification Initial Pain Assessment: Medical History Initial or Ongoing Pain Assessment: Characterization of • Extent of disease Pain • Previous therapies: effective & failures • Location • Description • Treatment-related signs and • Intensity symptoms • Temporal nature • Other medical conditions – onset • Efficacy of previous – duration – chronic/acute/palliative therapy relationship to scheduled analgesic dose • Aggravating/alleviating factors • Efficacy of previous analgesic treatments • Effects on function Initial Pain Assessment: Initial Pain Assessment: Psychosocial Examination Physical Examination and Diagnostic Studies • Disease state: effects and understanding • Physical Examination: • Reactions to pain – Site of pain – meaning of pain – Adjacent sites (for referred pain) – coping strategies and support system – Sites of known disease/ tumor invasion – effects on function – effects on mood – Musculoskeletal and neurologic systems • Perceptions regarding analgesic therapy • Diagnostic Evaluation: – expectations, knowledge, and preferences – Laboratory studies/tumor markers – concerns regarding controlled substances – Radiologic studies • Financial concerns regarding therapy – Neurophysiologic testing *Assess whether low, medium, or high risk for abuse for – Urine drug screening chronic opioid therapy (COT). Z-4 American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Pain Assessment Tools: Intensity Simple Descriptive Pain Intensity Scale 0-10 Numeric Pain Intensity Scale 0 10 None Mild Moderate Severe Very Worst Severe Possible 0-10 Numeric Pain Intensity Scale 0 10 0 1 2 3 4 5 6 7 8 9 10 None Moderate Worst Possible Visual Analog Scale (VAS) 0 10 None Pain as bad as it could possibly be Faces scale reprinted with permission from Patt RB. Cancer Pain. Philadelphia: JB Lippincott Co.; 1993. Jacox A, et al. Management of Cancer Pain: Clinical Guideline No. 9. March 1994. AHCPR Publication No. 94-0592. SCREENER and OPIOID ASSESSMENT for PATIENTS with PAIN ( SOAPP), PAIN ASSESSMENT and DOCUMENTATION TOOL (PADT). OPIOID RISK TOOL. • SOAPP version 1.0 is an easy and relatively quick questionnaire to help physicians and providers evaluate patients’ risk for higher problems if long-term opioid therapy is to be considered. SOAPP is not a lie detector test. It is not intended for all patients. It is likely to predict which patients will need less or more close monitoring on long-term opioid therapy. Version 1.0 has 24 questions. Version 1.0 SF has 5 questions. 2 most important questions-Smoke and drink? PADT- Useful tool for clinicians evaluating care and outcomes during opioid therapy. Also Opioid Risk Tool. Z-5 American Osteopathic College of Occupational and Preventive Medicine 2015 Mid Year Educational Conference, Ft. Lauderdale, Florida Pharmacologic Management of Pain • Select the appropriate Drug. • Prescribe the appropriate Dose- do under or over treat. • Administer by the appropriate Route. • Schedule the appropriate dosing Interval- consider long acting for ATC, short acting for rescue/breakthrough. • Prevent Persistent pain/relieve Breakthrough pain. • Titrate doses aggressively. • Anticipate, prevent, and manage the Side Effects. • Use appropriate Adjuvant drugs when indicated. • Assess treatment response at regular intervals. Adapted from Levy MH. N Engl J Med 1996;335:1125. opioid Choice of Agent: The word opioid is a general term that Three-Step Analgesic Ladder refers to all compounds related to Morphine opium. The term narcotic(causing Opioid Fentanyl + Adjuvant Oxycodone narcosis) once used to refer to any Moderate/Severe 3 g + Nonopioid Hydromorphone n i s a e r drug
Load more

Recommended publications
  • Analgesia After Cesarean Section in Preeclampsia Parturients Receiving Magnesium Sulfate: a Retrospective Comparison with Non-Preeclampsia Parturients
    Anesth Pain Med 2012; 7: 136～141 ￭Clinical Research￭ Analgesia after Cesarean section in preeclampsia parturients receiving magnesium sulfate: a retrospective comparison with non-preeclampsia parturients † Department of Anesthesiology and Pain Medicine, *Seoul National University Bundang Hospital, Seongnam, Seoul National University ‡ Hospital, Boramae Medical Center, Seoul, Korea Hyo-Seok Na*, Hyun-Bin Kim†, Chong-Soo Kim‡, and Sang-Hwan Do* Background: Magnesium sulfate (MgSO4) is the first-line therapy Key Words: Cesarean section, Magnesium sulfate, Postoperative for managing preeclampsia in obstetrics. Its perioperative adminis- pain, Preeclampsia. tration has been proved to be an effective analgesic adjuvant, which we investigated in parturients undergoing Cesarean section (C-sec). Methods: A retrospective chart review examined 504 parturients INTRODUCTION who underwent C-secs between June 2006 and August 2010, including normal parturients (group N, n = 401) and those diagnosed In parturients with preeclampsia, magnesium sulfate (MgSO4) with preeclampsia (group P, n = 103). A postoperative numeric is the first choice drug for the prevention of eclamptic rating scale (NRS) was used to assess pain, and the number of seizures. It is administered routinely via a loading dose and rescue analgesic administrations and frequency of transfusions were investigated. Perioperative magnesium concentrations were recor- continuous infusion with a target serum concentration of 2− ded for patients in group P. 3.5 mmol/L during the antepartum period and is continued Results: Patients in group P had longer operation and anesthesia until at least 24 h postpartum [1]. times, and more postoperative admission days than those in group Magnesium acts as an N-methyl-D-aspartate (NMDA) recep- N.
    [Show full text]
  • Efficacy of Opioids and Non-Opioid Analgesics in the Treatment of Post Procedure Pain of Burned Patients: a Narrative Review
    Journal Pre-proof Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review Paola Andrea Chinchilla Hermida, Jairo Ricardo Moyano Acevedo PII: S0104-0014(21)00303-1 DOI: https://doi.org/10.1016/j.bjane.2021.07.022 Reference: BJANE 744243 To appear in: Brazilian Journal of Anesthesiology (English edition) Received Date: 1 October 2020 Accepted Date: 20 July 2021 Please cite this article as: Hermida PAC, Acevedo JRM, Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review, Brazilian Journal of Anesthesiology (English edition) (2021), doi: https://doi.org/10.1016/j.bjane.2021.07.022 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier. BJAN-D-20-00269 - Narrative Review Efficacy of opioids and non-opioid analgesics in the treatment of post procedure pain of burned patients: a narrative review Paola Andrea Chinchilla Hermidaa,*, Jairo Ricardo Moyano Acevedob a Universidad El Bosque, Medicina Del Dolor y Cuidados Paliativos, Bogota, Colombia b Fundación Santafé Bogotá, Anesthesia Department, Pain Service, Bogota, Colombia * Corresponding author.
    [Show full text]
  • Enhancement of Antinociception but Not Constipation by Combinations
    Archives of Medical Research 44 (2013) 495e503 ORIGINAL ARTICLE Enhancement of Antinociception but not Constipation by Combinations Containing Tramadol and Metamizole in Arthritic Rats Francisco Javier Lopez-Mu noz,~ a Luis Alfonso Moreno-Rocha,a Guadalupe Bravo,a Uriah Guevara-Lopez, b Adriana Miriam Domınguez-Ramırez,c and Myrna Deciga-Camposd aDepartamento de Farmacobiologıa, Centro de Investigacion y Estudios Avanzados, Sede Sur, Mexico, D.F., Mexico bDireccion de Educacion e Investigacion en Salud, Unidad Medica de Alta Especialidad Dr. Victorio de la Fuente Narvaez, Instituto Mexicano del Seguro Social, Mexico, D.F., Mexico cDepartamento Sistemas Biologicos, Universidad Autonoma Metropolitana, Unidad Xochimilco, Mexico, D.F., Mexico dSeccion de Posgrado e Investigacion de la Escuela Superior de Medicina del Instituto Politecnico Nacional, Mexico, D.F., Mexico Received for publication February 1, 2013; accepted August 26, 2013 (ARCMED-D-13-00072). Background and Aims. The use of a combination of analgesics could provide an optimal pain treatment with minimal side effects. Combinations of tramadol and some nonste- roidal anti-inflammatory drugs have demonstrated synergistic antinociceptive effects as well as a significantly reduced occurrence of adverse effects. The purpose of this study was to investigate the antinociceptive and constipation effects of tramadol and metami- zole alone or in combination in rats and to discern among the types of drug interactions that exist using dose-response curves and an isobolographic analysis. Methods. The antinociceptive effects of tramadol and metamizole, alone or in various combination ratios, were quantitatively evaluated using the ‘‘pain-induced functional impairment model in the rat.’’ Additionally, the constipation effect was evaluated using the charcoal meal test.
    [Show full text]
  • Acetaminophen, Caffeine and Dihydrocodeine Bitartrate* Tablets CIII 712.8 Mg/60 Mg/32 Mg Rx Only Code 790Z00 Rev
    ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE- acetaminophen, caffeine and dihydrocodeine bitartrate tablet MIKART, INC. ---------- Acetaminophen, Caffeine and Dihydrocodeine Bitartrate* Tablets CIII 712.8 mg/60 mg/32 mg Rx only Code 790Z00 Rev. 02/99 DESCRIPTION Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablets are supplied in tablet form for oral administration. Each tablet contains: Acetaminophen..........................................................712.8 mg Caffeine.....................................................................60 mg Dihydrocodeine Bitartrate*..........................................32 mg (*Warning: May be habit forming) Acetaminophen (4'-hydroxyacetanilide), a slightly bitter, white, odorless, crystalline powder, is a non- opiate, non-salicylate analgesic and antipyretic. It has the following structural formula: C8H9NO2 M.W. = 151.17 Caffeine (1,3,7-trimethylxanthine), a bitter, white powder or white-glistening needles, is a central nervous system stimulant. It has the following structural formula: C8H10N4O2 (anhydrous) M.W. = 194.19 Dihydrocodeine bitartrate (4,5α-Epoxy-3-methoxy-17-methylmorphinan-6α-ol (+)-tartrate), an odorless, fine white powder is an opioid analgesic. It has the following structural formula: C18H23NO3•C4H6O6 M.W. = 451.48 In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, stearic acid, D&C Red #27 Aluminum Lake, D&C Red #30
    [Show full text]
  • Why Ketamine? Presentation
    WhyWhy Ketamine?Ketamine? JenniferJennifer Davis,Davis, M.D.M.D. HospiceHospice andand PalliativePalliative CareCare CenterCenter MayMay 13,13, 20112011 ObjectivesObjectives BeBe familiarfamiliar withwith thethe pharmacology,pharmacology, dosing,dosing, andand administrationadministration ofof KetamineKetamine UnderstandUnderstand thethe indications,indications, contraindications,contraindications, benefits,benefits, andand sideside effectseffects ofof KetamineKetamine KnowKnow thethe variousvarious usesuses ofof KetamineKetamine andand itsits abuseabuse potentialpotential HistoryHistory DevelopedDeveloped inin earlyearly 1960s1960s andand FDAFDA approvedapproved inin 19701970 FirstFirst usedused inin soldierssoldiers inin VietnamVietnam WarWar forfor warfarewarfare surgicalsurgical proceduresprocedures ClassifiedClassified asas scheduleschedule IIIIII drugdrug AugustAugust 19991999 OutlawedOutlawed inin UnitedUnited KingdomKingdom JanuaryJanuary 20062006 HistoryHistory AccordingAccording toto DEA,DEA, 80%80% seizedseized isis fromfrom MexicoMexico MostMost commonlycommonly usedused inin clubsclubs atat ravesraves 20022002 statistic,statistic, almostalmost 3%3% ofof 1212th gradegrade studentsstudents admittedadmitted toto usingusing ketamineketamine inin thethe lastlast yearyear Rave?Rave? HistoryHistory TheThe ScientistScientist byby JohnJohn LillyLilly JourneysJourneys intointo thethe BrightBright WorldWorld byby MarciaMarcia MooreMoore andand HowardHoward AlltounianAlltounian TheThe EssentialEssential PsychedelicPsychedelic
    [Show full text]
  • Evaluation of Potential Drug Interaction of Analgesic in Cancer
    Original Article 1 Pharmaceutical Sciences and Research (PSR), 7(1), 2020, 1 - 8 Evaluation of Potential Drug Interaction of Analgesic in Cancer Patient Receiving Palliative Care in Dharmais Cancer Hospital Eme Stepani Sitepu*, Atika Wahyu Puspitasari, Nuriza Ulul Azmi, Lila Nilam Sari Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia ABSTRACT Analgesics are mostly used in cancer patients receiving palliative care to improve the quality of life of patients. Besides analgesics, cancer patients receiving palliative care were also given other drugs in combination to overcome other symptoms of cancer, and this combination could potentially cause drug interactions. This study was aimed to analyze the potential of drug interactions with analgesics in cancer patients. The study design was cross-sectional with a retrospective method and descriptive ARTICLE HISTORY study. The sample of this study was cancer palliative care patient’s prescription at Dharmais Cancer Received: August 2019 Hospital in the period of January – December 2017. The sample analyzed in this study consisted of 273 Revised: February 2020 prescriptions. This study found that there were 191 prescriptions (69.9%) of analgesics which potential- Accepted : April 2020 ly interacted with 316 interaction cases. Fentanyl and morphine with 61 cases (19.3%), morphine and gabapentin with 60 cases (18.9%) and morphine and amitriptyline with 33 cases (10.4%) were observed as the three most analgesics-other drugs interaction. Based on severity levels, there were 73.5% of major interaction, 26.3% of moderate interaction, and 0.2% of minor interaction. This study concluded that high occurrence of drug interactions was observed in analgesic drugs, therefore close monitoring is needed in cancer patient receiving palliative care.
    [Show full text]
  • Assessment and Management of Cancer Pain
    3601_e23_p493-535 2/19/02 9:05 AM Page 493 23 Assessment and Management of Cancer Pain SURESH K. REDDY AND C. STRATTON HILL, JR. PREVALENCE OF CANCER PAIN that pain is only one aspect of suffering, it is often a major one. Comprehensive management of the can- It is estimated that from 30% to 50% of patients ac- cer patient with pain requires that all of the factors tively undergoing cancer therapy and from 60% to associated with the quality of life of the person as a 90% of patients with advanced cancer have pain (Fo- whole be considered. ley, 1979; Bonica, 1990; Twycross and Fairfield, 1982; World Health Organization, 1986; Levin et al., 1985). Approximately 50% of children in an inpatient UNDERTREATMENT OF CANCER PAIN pediatric cancer center and about 25% of outpatients experience pain (Miser et al., 1987). The World It is a sad fact that pain is not satisfactorily managed Health Organization Cancer Pain Relief Program in- for many cancer patients. For example, in one pub- dicates that approximately 5 million people world- lished study, 1308 patients were surveyed at 54 treat- wide suffer from cancer-related pain on a daily ba- ment sites participating in the Eastern Cooperative sis, and fully 25% of them die at home or in a hospital Oncology Group to evaluate the prevalence of pain without relief (World Health Organization, 1990). and the adequacy of its treatment (Cleeland et al., It is important to assess the effects of pain on the 1994). In this study, 67% of patients reported daily quality of life in multidimensional terms, and the de- pain and took analgesics daily.
    [Show full text]
  • The Journal of Veterinary Medical Science
    Advance Publication The Journal of Veterinary Medical Science Accepted Date: 13 Mar 2019 J-STAGE Advance Published Date: 25 Mar 2019 ACUPUNCTURE FOR POSTOPERATIVE ANALGESIA 1 FULL PAPER 2 3 Surgery 4 5 Analgesic efficacy of laser acupuncture and electroacupuncture in cats undergoing 6 ovariohysterectomy 7 8 9 Felipe F. NASCIMENTO, Vírginia I. MARQUES, Giulianne C. CROCIOLLI, Gabriel M. 10 NICÁCIO, Isabela P. A. G. NICÁCIO and Renata N. CASSU 11 12 13 Department of Veterinary Surgery and Anestesiology, Faculty of Veterinary Medicine, 14 Universidade do Oeste Paulista, Presidente Prudente, Brazil. 15 16 Correspondence to Cassu, R.N. Department of Veterinary Surgery and Anesthesiology, Faculty 17 of Veterinary Medicine and Animal Science, Unoeste, 19067-175, Presidente Prudente, Brazil. 18 19 20 Corresponding author. Tel: +551832292077 21 E-mail: [email protected]/ [email protected] 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 1 ACUPUNCTURE FOR POSTOPERATIVE ANALGESIA 46 ABSTRACT. The aim of this study was to compare the effects of laser acupuncture and 47 electroacupuncture on postoperative pain and analgesic requirements in cats. In a prospective, 48 randomized and blinded clinical study, thirty cats undergoing ovariohysterectomy were sedated 49 with intramuscular (IM) ketamine (5 mg/kg), midazolam (0.5 mg/kg), and tramadol (2 mg/ kg). 50 Before the induction of anesthesia, the animals were randomly distributed into three groups of 51 ten cats each: LA: bilateral Stomach 36 (ST-36) and Spleen 6 (SP-6) acupoints were stimulated 52 with an infrared laser; EA: bilateral ST-36 and SP-6 acupoints were stimulated with an electrical 53 stimulus; Control: no acupuncture was applied.
    [Show full text]
  • Administration of IV Anesthetic Agent Ketamine for Inpatient Treatment of PAGE 1 of 3 Intractable Pain
    STRONG MEMORIAL HOSPITAL POLICY MANUAL SECTION #8 GENERAL PATIENT CARE DATE 5-10 8.11.3 Administration of IV Anesthetic Agent Ketamine for Inpatient Treatment of PAGE 1 of 3 Intractable Pain P O L I C Y Ketamine is an anesthetic with analgesic, sedative, amnesic and dissociative properties. The analgesic effect is thought to be related to antagonism of the N-methyl-d-aspartate (NMDA) receptors in the dorsal horn of the spinal cord and enhancement of endogenous pain inhibitory neurotransmitters. This medication is used to treat patients with severe neuropathic and somatic pain that responds poorly to opioid analgesics and may reduce tolerance to opioids and reverse opioid induced hyperalgesia in some situations . Additional central nervous system effects include inhibition of dopamine and serotonin reuptake and elevation of epinephrine and norepinephrine. Ketamine infusion (IV or SQ) may be considered as an adjunctive analgesic for patients with intractable pain that is not controlled with current analgesic regimen as determined by a pain management physicians /anesthesiologist or palliative care physician. 1) Consultation and recommendations by the Anesthesia Pain Service and/or Palliative Care Service are required to ensure that all other pain management measures have been considered, and for guidance in the process. 2) The patient must be admitted to a nursing unit that is designated by the institution as an acceptable site (e.g., critical care, hospice or palliative care) for the administration of IV ketamine for intractable pain. 3) The patient must provide verbal or written consent prior to initiation of treatment. If the patient lacks capacity, the decision would be made in a manner consistent with decisions to withhold or withdraw care for a patient who lacks capacity (see SMH Policy 9.3.3).
    [Show full text]
  • Ketamine Parenteral and Oral Dose Recommendations
    Ketamine Parentera l and Oral Dose Recommendations • Pharmacology o Inhibits glutamate binding to NMDA-R receptor; activity at norepinephrine, serotonin, and muscarinic cholinergic, kappa opioid, and voltage-sensitive calcium channel receptors • Pharmacokinetics o Lipophilic; Crosses blood brain barrier o Protein binding : 47% o Onset of action: 1- 5 min IV/IM, 15-30 min SC; 30 min o Plasma half-life: 1- 3 hrs (ketamine); 12 hrs (norketamine o Duration of action: 4- 12 hrs (oral); 10-15 min IV o Metabolism: N- demethylation via CYP2B6, CYP 2C8/9, CYP 3A4 substrates to norketamine (primary metabolite); norketamine metabolized via hydroxylation and conjugation o Elimination: Primarily hydroxylated or conjugated norketamine metabolites in urine; 4% unchanged ketamine or norketamine; <5% elimination in feces • Drug Interactions o Increased ketamine levels with concurrent use of CYP2B6 or CYP2C8/9 inhibitors • Adverse effects o Central nervous system: Alterations in body image/mood, floating sensations, vivid dreams, hallucinations, delirium, purposeless movement, drowsiness, increased intraocular pressure, increased intracranial pressure, increased muscle tone, memory impairment (long-term use) o Gastrointestinal: Nausea and vomiting, hepatic damage (long-term oral use) o Cardiovascular: HTN, tachyarrhythmias o Misc: lacrimation, salivation, ulcerative cystitis (long term oral use) Route of Available Product How product is stocked Usual Doses Administration Oral Compounded 30mg, 60mg capsules 1mg PO Ketamine = 1mg IV Ketamine capsules • Reported
    [Show full text]
  • Meta-Analysis of Herbal Cannabis Therapy for Chronic Pain Michael J
    UNF Digital Commons UNF Graduate Theses and Dissertations Student Scholarship 2014 Meta-Analysis of Herbal Cannabis Therapy for Chronic Pain Michael J. Seneca University of North Florida Suggested Citation Seneca, Michael J., "Meta-Analysis of Herbal Cannabis Therapy for Chronic Pain" (2014). UNF Graduate Theses and Dissertations. 503. https://digitalcommons.unf.edu/etd/503 This Doctoral Project is brought to you for free and open access by the Student Scholarship at UNF Digital Commons. It has been accepted for inclusion in UNF Graduate Theses and Dissertations by an authorized administrator of UNF Digital Commons. For more information, please contact Digital Projects. © 2014 All Rights Reserved META-ANALYSIS OF HERBAL CANNABIS THERAPY FOR CHRONIC PAIN by Michael J. Seneca A project submitted to the School of Nursing in partial fulfillment of the requirements for the degree of Doctor of Nursing Practice UNIVERSITY OF NORTH FLORIDA BROOKS COLLEGE OF HEALTH March 2014 Unpublished work c. Michael J. Seneca Certificate of Approval The project of Michael J. Seneca is approved: 7-12-2013 Dan Richard, PhD Date Committee Member 7-12-2013 Jonathan Pabalate, DNP, CRNA Date Committee Member 7-12-2013 Carol Ledbetter, PhD, FNP, BC, FAAN Date Committee Member 7-12-2013 Doreen Radjenovic, PhD, ARNP, BC Date Committee Chairperson Accepted for the School of Nursing: Lillia Loriz, PhD, GNP, BC Date Director, School of Nursing Accepted for the College: Pamela S. Chally, PhD, RN Date Dean, Brooks College of Health Accepted for the University Len Roberson, PhD Date Dean of the Graduate School iii Dedication & Acknowledgements I would like to thank Dr.
    [Show full text]
  • Comparison of Intrathecal Tramadol and Magnesium Sulfate As An
    Indian Journal of Clinical Anaesthesia 2019;6(4):481–487 Content available at: iponlinejournal.com Indian Journal of Clinical Anaesthesia Journal homepage: www.innovativepublication.com Original Research Article Comparison of intrathecal Tramadol and Magnesium sulfate as an adjuvant to Levobupivacaine in mild Pre-eclamptic parturients undergoing caesarean section- A prospective randomized control study. Aditi A Dhimar1,*, Vallary Modh1, M R Upadhyay1 1Dept. of Anaesthesiology, Medical College and S.S.G. Hospital, Vadodara, Gujarat, India ARTICLEINFO ABSTRACT Article history: Aims and Objective: Spinal anaesthesia is advantageous as compare to general anaesthesia for cesarean Received 02-05-2019 section especially in preeclampsia as it avoids the complications of general anaesthesia. To improve the Accepted 29-08-2019 quality of sensory and motor blockade and prolong the duration of postoperative analgesia, we had used Available online 20-11-2019 tramadol and magnesium sulfate intrathecally with the primary aim to assess sensory and motor blockade and postoperative analgesia. Material and Methods: This prospective randomized control study included sixty preeclamptic parturient Keywords: having more than 36 weeks of pregnancy with controlled hypertension aged 18-40 years with single Intrathecal pregnancy, planned for caesarean section of ASAPS II, III and able to understand VAS score were included. Levobupivacaine Parturients were randomly assigned to g roup LT (injection Levobupivacaine 0.5%, 1.5ml + injection Magnesium sulfate Tramadol 25 mg,0.5ml) and group LM (injection Levobupivacaine 0.5%, 1.5ml + injection Magnesium Preeclampsia sulfate 100 mg,0.5ml) using computer generated random numbers and the assignment was sealed in Tramadol envelopes for concealment. They were assessed for sensory blockade, motor blockade and postoperative analgesia.
    [Show full text]